{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:43:47Z","timestamp":1765827827747,"version":"3.30.1"},"reference-count":17,"publisher":"Medknow","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smedj"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.11622\/smedj.2019092","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T06:58:02Z","timestamp":1565161082000},"page":"24-27","source":"Crossref","is-referenced-by-count":5,"title":["Cost-effectiveness analysis of antiviral treatment for pregnant women with high viral load to prevent hepatitis B virus vertical transmission"],"prefix":"10.4103","volume":"61","author":[{"given":"T","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LY","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MM","family":"Aw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GH","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","published-online":{"date-parts":[[2020,1]]},"reference":[{"key":"ref0","unstructured":"1. Navabakhsh, B, Mehrabi N, Estakhri A, Mohamadnejad M, Poustchi H. Hepatitis B virus infection during pregnancy: transmission and prevention. Middle East J Dig Dis 2011; 3:92-102."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12879-016-1734-5","article-title":"Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen","volume":"16","author":"Jourdain","year":"2016","unstructured":"2. Jourdain, G, Ngo-Giang-Huong N, Cressey TR, et al. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. BMC Infect Dis 2016; 16:393.","journal-title":"BMC Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","article-title":"Perinatal transmission of hepatitis B virus: an Australian experience","volume":"190","author":"Wiseman","year":"2009","unstructured":"3. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190:489-92.","journal-title":"Med J Aust"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00431-006-0327-5","article-title":"Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus","volume":"166","author":"Song","year":"2007","unstructured":"4. Song YM, Sung J, Yang S, et al. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007; 166:813-8.","journal-title":"Eur J Pediatr"},{"key":"ref4","unstructured":"5. Vertical transmission of hepatitis B despite immunoprophylaxis. Adverse Drug Reaction News [serial online] 2012; 14. Available at: http:\/\/www.hsa.gov.sg\/content\/dam\/HSA\/HPRG\/Safety_Alerts_Product_Recalls_Enforcement\/Adverse_Drug_Reaction_News\/2012\/ADR_News_Dec2012_Vol14_No.3.pdf. Accessed January 26, 2018."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/jmv.24193","article-title":"Hepatitis B immunoprophylaxis failure and the presence of hepatitis B surface gene mutants in the affected children","volume":"87","author":"Lee","year":"2015","unstructured":"6. Lee LY, Aw M, Rauff M, et al. Hepatitis B immunoprophylaxis failure and the presence of hepatitis B surface gene mutants in the affected children. J Med Virol 2015; 87:1344-50.","journal-title":"J Med Virol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"CQ","year":"2016","unstructured":"7. Pan CQ, Duan Z, Dai E, et al; China Study Group for the Mother-to-Child Transmission of Hepatitis B. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 2016; 374:2324-34.","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","article-title":"Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study","volume":"16","author":"WM","year":"2009","unstructured":"8. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16:94-103.","journal-title":"J Viral Hepat"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","article-title":"A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection","volume":"55","author":"Han","year":"2011","unstructured":"9. Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011; 55:1215-21.","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57:167-85.","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"NA","year":"2016","unstructured":"11. Terrault NA, Bzowej NH, Chang KM, et al; American Association for the Study of Liver Diseases. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016; 63:261-83.","journal-title":"Hepatology"},{"key":"ref11","unstructured":"12. Lee LY, Aw M, Chan SM, Saw S, Lee GH. Infant outcomes of antenatal maternal hepatitis B treatment during pregnancy. Poster presented at the European Society for Paediatric Infectious Diseases, Madrid, Spain, 23-27 May 2017. Abstract No. ESP17-0173. Available at: http:\/\/espid2017.kenes.com\/Documents\/ESPID17%20abstracts.pdf. Accessed January 26, 2018."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Werner EF, Wheeler S, Burd I. Creating decision trees to assess cost-effectiveness in clinical research. J Biomet Biostat 2012; S7:004.","DOI":"10.4172\/2155-6180.S7-004"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Li SC, Ong SC, Lim SG, et al. A cost comparison of management of chronic hepatitis B and its associated complications in Hong Kong and Singapore. J Clin Gastroenterol 2004; 38(10 Suppl 3):S136-43.","DOI":"10.1097\/00004836-200411003-00004"},{"key":"ref14","unstructured":"15. Department of Statistics, Singapore. Yearbook of Statistics Singapore, 2018. Available at: https:\/\/www.singstat.gov.sg\/-\/media\/files\/publications\/reference\/ yearbook_2018\/yos2018.pdf. Accessed July 30, 2019."},{"key":"ref15","unstructured":"16. Ministry of Health, Singapore. Drug subsidies and schemes. Available at: https:\/\/www.moh.gov.sg\/content\/moh_web\/home\/costs_and_financing\/schemes_subsidies\/drug_subsidies.html. Accessed January 26, 2018."},{"key":"ref16","unstructured":"17. Jacobs A. China to end required testing for Hepatitis B. The New York Times 2009 Oct 12; Page A5. Available at: https:\/\/www.nytimes.com\/2009\/10\/13\/world\/asia\/13beijing.html. Accessed August 1, 2019."}],"container-title":["Singapore Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.smj.org.sg\/article\/cost-effectiveness-analysis-antiviral-treatment-pregnant-women-high-viral-load-prevent","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:49:55Z","timestamp":1660042195000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.smj.org.sg\/article\/cost-effectiveness-analysis-antiviral-treatment-pregnant-women-high-viral-load-prevent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]},"published-print":{"date-parts":[[2020,1]]}},"URL":"https:\/\/doi.org\/10.11622\/smedj.2019092","relation":{},"ISSN":["0037-5675"],"issn-type":[{"type":"print","value":"0037-5675"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}